Bharathan, R.; Polterauer, S.; Lopez-Sanclemente, M.C.; Trukhan, H.; Pletnev, A.; Heredia, A.G.; Gil, M.M.; Bakinovskaya, I.; Dalamanava, A.; Romeo, M.;
et al. Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma. J. Pers. Med. 2024, 14, 155.
https://doi.org/10.3390/jpm14020155
AMA Style
Bharathan R, Polterauer S, Lopez-Sanclemente MC, Trukhan H, Pletnev A, Heredia AG, Gil MM, Bakinovskaya I, Dalamanava A, Romeo M,
et al. Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma. Journal of Personalized Medicine. 2024; 14(2):155.
https://doi.org/10.3390/jpm14020155
Chicago/Turabian Style
Bharathan, Rasiah, Stephan Polterauer, Martha C. Lopez-Sanclemente, Hanna Trukhan, Andrei Pletnev, Angel G. Heredia, Maria M. Gil, Irina Bakinovskaya, Alena Dalamanava, Margarita Romeo,
and et al. 2024. "Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma" Journal of Personalized Medicine 14, no. 2: 155.
https://doi.org/10.3390/jpm14020155
APA Style
Bharathan, R., Polterauer, S., Lopez-Sanclemente, M. C., Trukhan, H., Pletnev, A., Heredia, A. G., Gil, M. M., Bakinovskaya, I., Dalamanava, A., Romeo, M., Rovski, D., Baquedano, L., Chiva, L., Schwameis, R., Zapardiel, I., & on behalf of SARCUT Study Group.
(2024). Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma. Journal of Personalized Medicine, 14(2), 155.
https://doi.org/10.3390/jpm14020155
